INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
NHS is not just playing with fire, it's lighting them—all part of the (hairbrained) plan

NHS is not just playing with fire, it's lighting them—all part of the (hairbrained) plan

More joining of dots in the UKs quest to conquer the world with gene therapy

Hedley Rees's avatar
Hedley Rees
Nov 21, 2022
∙ Paid
28

Share this post

INSIDE PHARMA
INSIDE PHARMA
NHS is not just playing with fire, it's lighting them—all part of the (hairbrained) plan
13
Share

What is ‘The ATTC project?’

ATTC stands for “Advanced Therapy Treatment Centres”. Its website explains the mission:

“Our Mission

The ATTC project aims to develop robust systems for the routine delivery of ATMPs as a standard of care throughout the NHS in the United Kingdom.”

It then goes on to say:

“Over the last five years, new cell and gene therapies have been developed to treat some cancers and inherited diseases. These advanced therapies are different from existing treatments in two important ways: they are designed to restore normal function, sometimes offering cures where an unmet medical need exists and they require new ways of working by the NHS.”

The truth is very different

Some very disturbing facts seem to have been missed out. Nearly all the potential for gene therapies is wrapped up in rare blood cancers, where the treatment is known as CAR T.

The first to market was Novartis’ Kymriah, approved August 2017:

  • Price at launch was $475,000.

  • Hospitals have to fund additional heavy ove…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share